CD44 and breast carcinoma: Breast cancer stem cells (BCSCs) were a tumorigenic subset of breast cancer cells first isolated from human breast tumors with the expression of the surface markers CD44+/CD24−, which are the radical cause of drug resistance, tumor relapse, and metastasis in breast cancer.